Healthy Volunteers Clinical Trial
— ActiGPSOfficial title:
Assessment of Human Locomotion and Energy Expenditure Using Global Positioning Satellite and Accelerometry
| Verified date | November 2019 |
| Source | University Hospital, Angers |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The aim of the study is to validate the association of the GPS and accelerometer tools in
order to assess the humain locomotion during exercises.
The hypotheses are:
1. GPS and accelerometer together can assess the human locomotion
2. GPS and accelerometer together can assess the energy expenditure during exercises
| Status | Completed |
| Enrollment | 67 |
| Est. completion date | June 8, 2016 |
| Est. primary completion date | June 8, 2016 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Older than 18 - Informed consent of the participant - Able to understand the protocol of the study - Register to the social health insurance - No exercise limitation Exclusion Criteria: - No informed consent of the participant - pregnant woman |
| Country | Name | City | State |
|---|---|---|---|
| France | University Hospital | Angers |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Angers | École Normale Supérieure de Cachan, Institut de Formation en Education Physique et en Sport d'Angers/Les Ponts de Cé |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Determine the accuraccy of GPS and acceleropmetry to estimate energy expediture in healthy volunteers | Recording of VO2 real time with a portable analyser in parallel to GPS and accelerometry. Prediction (determined by the coefficient of determination from linear regression) of energy expenditure during level and grade outdoor walking and running from: i) GPS alone; ii) Accelerometer alone; iii) both GPS and accelerometer. |
up to 1 week | |
| Primary | Defining optimal analysis parameter to accurately detect walking from stopping periods | Predefined walking protocols will be recorded and the subjects asked to follow recorded procedures. Detection performance of walking and resting bouts (expressed by the percentage accuracy in the detection of walking and resting bouts actually performed) for: i) GPS alone; ii) Accelerometer alone; iii) both GPS and accelerometer |
up to 1 week | |
| Secondary | Defining optimal analysis parameter to accurately detect speed and distance of periods of walking | Predefined walking protocols will be recorded and the subjects asked to follow recorded procedures at a defined walking pace. Accuracy of speed and distance estimations (expressed by the typical error of estimate and the coefficient of variation) from: i) GPS alone; ii) Accelerometer alone; iii) both GPS and accelerometer. |
up to 1 week |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |